Marketwatch

Biocon subsidiary caught offering bribe to waive off trial of new drug

Admin June 21, 2022

The CBI apprehended Joint Drugs Controller S. Eswara Reddy for allegedly receiving a ₹4-lakh bribe to waive phase-three clinical trial of Insulin Aspart injection, an underdevelopment product of Biocon Biologics, officials said

The Hindu – Economy

Share on Facebook
Tweet it
Pin it
Share it
Email

Breaking News

‘GST spurring fresh tax terrorism,’ says former CEA Arvind Subramanian

Fiscal deficit at 46.5% of full-year target at October-end: Govt data

Govt mulls change in base year to 2022-23 from 2011-12 for computation of GDP

India’s real GDP growth slumps to multi-quarter low of 5.4%

PM’s entire focus not on reducing inflation but on data manipulation, propaganda: Congress

Time to upgrade Indo-French trade relations: Commerce Minister Goyal

Recommendation from Group of Ministers awaited for GST exemption on health, life insurance

After Fitch, Moody’s also switches outlook on Adani group firms to ‘negative’

PAN 2.0 Project: All you need to know

S&P cuts India’s GDP growth forecast for FY26, FY27

Biocon subsidiary caught offering bribe to waive off trial of new drug